[1]
“Immunotherapy-Induced Acute Gastritis: First Case Report of Nivolumab Re-Challenge after Severe Immune-Mediated Inflammatory Response”, acmcr, vol. 6, no. 2, pp. 182–188, Mar. 2022, Accessed: Sep. 11, 2026. Available: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22594